Are You Sure You Have a Good Model?

Pharmacophores and Pharmacophore Searches

Volumn , Issue , 2006, Pages 325-364

  Triballeau, Nicolas ^a   Bertrand, Hugues Olivier ^a   Acher, Francine ^b  

^a Parc Club Orsay Universite   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Hit identification; Lead profiling; New pharmacophore model for mGlu4R agonists; Pharmacophores; Software related validation methods; Validation methods; Validation of pharmacophore models; Visual inspection

Indexed keywords

PHARMACOPHORE MODELING; PHARMACOPHORE MODELS; PHARMACOPHORES; VALIDATION METHODS; VISUAL INSPECTION;

PHARMACODYNAMICS;

EID: 77954814607     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527609164.ch15     Document Type: Chapter

References (100)

1. P. Ehrlich, Ber. Dtsch. Chem. Ges. 1909, 42, 17-47.
2. P. Gund, in Progress in Molecular and Subcellular Biology, F. E. Hahn (ed.). Springer, Berlin, 1977, pp. 117-143.
3. J.S. Mason, A.C. Good, E. J. Martin, Curr. Pharm. Des. 2001, 7, 567-597.
4. C.G. Wermuth, C.R. Ganellin, P. Lind- berg, L.A. Mitscher, Pure Appl. Chem. 1998, 70, 1129-1143.
5. H. van de Waterbeend, R.E. Carter, G. Grassy, H. Kubinyi, Y.C. Martin, M.S. Tute, P. Willett, Pure Appl. Chem. 1997, 69, 1137-1152.
6. J.H. Van Drie, in Pharmacophore Percep- tion, Development and Use in Drug design, O.F. Güner (ed.), International Univer- sity Line, La Jolla, CA, 2000, pp. 50-68.
7. J.H. Van Drie, in Computational Medic- inal Chemistry for Drug Discovery, P. Bul- tinck, H. DeWinter, W. Langenaeker and J. P. Tollenaere (eds.). Marcel Dekker, New York, 2004, pp. 437-460.
8. S. J. Teague, Nat. Rev. Drug Discov. 2003, 2, 527-541.
9. Accelrys. Catalyst ®. Accelrys, San Diego, CA; www.accelrys.com.
10. D. Barnum, J. Greene, A. Smellie, P. Sprague, J. Chem. Inf. Comput. Sci. 1996, 36, 563-571.
11. H. Li, J. Sutter, R. Hoffmann, in Phar- macophore Perception, Development and Use in Drug Design, O.F. Güner (ed.). La Jolla CA, 2000, pp. 171-189.
12. Tripos. DISCO (DIStance COmparisons), available as DISCOtechTM from Tripos, Inc., St. Louis, MO, with additional im- plemented functionalities; www.tripos.- com.
13. Y.C. Martin, E. Dahaner, J. De Lazzer, I. Lico, P.A. Pavlik, J. Comput.-Aided Mol. Des. 1993, 7, 83-102.
14. Y.C. Martin, in Pharmacophore Percep- tion, Development and Use in Drug Design, O. F. Güner (ed). La Jolla, CA, 2000, pp. 49-68.
15. Tripos. GASPTM (Genetic Algorithm Simi- larity Program). Tripos, Inc., St. Louis, MO; www.tripos.com.
16. G. Jones, P. Willett, R.C. Glen, J. Comp.- Aided Mol. Des. 1995, 9, 532-549.
17. Schrödinger. Phase. Schrödinger, LLC, New York; www.schrodinger.com.
18. R. Dayam, T. Sanchez, O. Clement, R. Shoemaker, S. Sei, N. Neamati, J. Med. Chem. 2005, 48, 111-120.
19. Internal randomization studies per- formed by Accelrys, Inc., San Diego, CA.
20. Computer Consulting Group. MOETM (Molecular Operating Environment). Com- puter Consulting Group, Montreal.
21. Accelrys. DS ViewerPro. Accelrys, Inc., San Diego, CA.
22. G. Wolber, T. Langer, J. Chem. Inf. Model. 2005, 45, 160-169.
23. Inte:Ligand. LigandScout. Inte:Ligand, GmbH, Maria Enzerdorf, Austria; www.inteligand.com.
24. C.M. Venkatachalam, P. Kirchhoff, M. Waldman, in Pharmacophore Perception, Development and Use in Drug Design,O. F. Güner (ed.). La Jolla, CA, 2000, pp. 339-350.
25. H.A. Carlson, K.M. Masukawa, K. Ru- bins, F.D. Bushman, W.L. Jorgensen, R.D. Lins, J.M. Briggs, J.A. McCam-mon, J. Med. Chem. 2000, 43, 2100- 2114.
26. H.A. Carlson, K.M. Masukawa, J.A. McCammon, J. Phys. Chem. A 1999, 103, 10213-10219.
27. R.D. Cramer III, D.E. Patterson, J.D. Bunce, J. Am. Chem. Soc. 1988, 110, 5959-5967.
28. G. Klebe, U. Abraham, T. Mietzner, J. Med. Chem. 1994, 37, 4130-4146.
29. R.A. Glennon, S.Y. Ablordeppey, A.M. Ismaie, M.B. El-Ashmawy, J.B. Fischer, K.B. Howie, J. Med. Chem. 1994, 37, 1214-1219.
30. R. Barbaro, L. Betti, M. Botta, F. Corelli, G. Giannaccini, L. Maccari, F. Manetti, G. Strappaghetti, S. Corsano, Bioorg. Med. Chem. 2002, 10, 361-369.
31. N. Jullian, I. Brabet, J.-P. Pin, F.C. Acher, J. Med. Chem. 1999, 42, 1564- 1555.
32. A.-S. Bessis, N. Jullian, E. Coudert, J.-P. Pin, F. Acher, Neuropharmacology 1999, 38, 1543-1551.
33. N. Kunishima, Y. Shimada, Y. Tsuji, T. Sato, M. Yamamoto, T. Kumasaka, S. Na- kanishi, H. Jingami, K. Morikawa, Na- ture 2000, 407, 971.
34. Apex-3D. Originally developed by V. Go- lender, B. Vesterman and E. Vorpagel, this software is no longer distributed.
35. D. J. Livingstone, Data Analysis for Che- mists: Applications to QSAR and Chemical Product Design. Oxford University Press, New York, 1995.
36. H. Kubinyi, Drug Discov. Today 1997, 2, 538-546.
37. H. Kubinyi, Drug Discov. Today 1997, 2, 457-467.
38. D.M. Hawkins, S.C. Basak, D. Mills, J. Chem. Inf. Comput. Sci. 2003, 43, 579- 586.
39. D.M. Hawkins, J. Chem. Inf. Comput. Sci. 2004, 44, 1-12.
40. A.M. Doweyko, J. Comput.-Aided Mol. Des. 2004, 18, 587-596.
41. R. Guha, P.C. Jurs, J. Chem. Inf. Model. 2005, 45, 65-73.
42. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P. E. Bourne, Nucleic Acids Res. 2000, 28, 235-242.
43. R. Brenk, L. Naerum, U. Grädler, H.-D. Gerber, G.A. Garcia, K. Reuter, M.T. Stubbs, G. Klebe, J. Med. Chem. 2003, 46, 1133-1143.
44. Tripos. SYBYL®. Tripos, Inc., St. Louis, MO.
45. A.K. Ghose, J. J. Wendoloski, Perspect. Drug Discov. Des. 1998, 9/10/11, 253- 271.
46. R.M. De Marinis, M. Wise, J.P. Hieble, R.R. Ruffolo Jr., R.R. Ruffolo Jr, in The Alpha-1 Adrenergic Receptors, R.R. Ruffo- lo Jr. (ed). Humana Press, Clifton, NJ, 1987, pp. 211-265.
47. C. Laggner, C. Schieferer, B. Fiechtner, G. Poles, R.D. Hoffmann, H. Gloss- mann, T. Langer, F.F. Moebius, J. Med. Chem. 2005, 48, 4754-4764.
48. H. Kubinyi, F. A. Hamprecht, T. Mietz- ner, J. Med. Chem. 1998, 41, 2553-2564.
49. P. Willett, J. Chem. Inf. Comput. Sci. 1998, 38, 983-996.
50. R.Wang, Y. Lu, X. Fang, S.Wang, J. Chem. Inf. Comput. Sci. 2004, 44, 2114-2125.
51. A.K. Debnath, Mini Rev. Med. Chem. 2001, 1, 187-195.
52. M.L. Verdonk, V. Berdini, M. J. Harts-horn, W.T.M. Mooij, C.W. Murray, R.D. Taylor, P. Watson, J. Chem. Inf. Comput. Sci. 2004, 44, 793-806.
53. N. Triballeau, F. Acher, I. Brabet, J.-P. Pin, H.-O. Bertrand, J. Med. Chem. 2005, 48, 2534-2547.
54. Thompson Derwent. Thompson Derwent World Drug Index; scientific.thomson.- com/products/wdi.
55. KEGG. KEGG Kyoto Encyclopedia of Genes and Genomes; www.kegg.com.
56. T.M. Frimurer, R. Bywater, L. Nrum, L.N. Lauritsen, S. Brunak, J. Chem. Inf. Comput. Sci. 2000, 40, 1315-1324.
57. A. Goldblum, personal communication, 2005.
58. S. Yoon, W. J. Welsh, J. Chem. Inf. Com- put. Sci. 2004, 44, 88-96.
59. O.F. Güner, D.R. Henry, in Pharmaco- phore Perception, Development and Use in Drug Design, O. F. Güner (ed.). La Jolla CA, 2000, pp. 193-212.
60. M. Jacobsson, P. Lidén, E. Stjernschantz, H. Boström, U. Norinder, J. Med. Chem. 2003, 46, 5781-5789.
61. E.A. Hecker, C. Duraiswami, T.A. An- drea, D. J. Diller, J. Chem. Inf. Comput. Sci. 2002, 42, 1204-1211.
62. D. J. Diller, R. Li, J. Med. Chem. 2003, 46, 4638-4647.
63. D. J. Diller, J. Kenneth M. Merz, Proteins: Struct. Funct. Genet. 2001, 43, 113-124.
64. J. Weston, F. Perez-Cruz, O. Bousquet, O. Chapelle, A. Elisseeff, B. Scholkopf, Bioinformatics 2003, 19, 764-771.
65. A. J. Shepherd, D. Gorse, J.M. Thornton, Protein Sci. 1999, 8, 1045-1055.
66. H. Gao, C. Williams, P. Labute, J. Bajor- ath, J. Chem. Inf. Comput. Sci. 1999, 39, 164-168.
67. M.G. Ford, presented at the 2nd CMTPI, Thessaloniki, Greece, 2003.
68. E.K. Bradley, J.L. Miller, E. Saiah, P.D. J. Grootenhuis, J. Med. Chem. 2003, 46, 4360-4364.
69. E.K. Bradley, P. Beroza, J.E. Penzotti, P.D. J. Grootenhuis, D.C. Spellmeyer, J.L. Miller, J. Med. Chem. 2000, 43, 2770-2774.
70. B. Matthews, Biochim. Biophys. Acta 1975, 405, 442-451.
71. E. Martineau, A.M. Aman, X. Kong, in Accelrysworld. Accelrys, Inc., San Diego, CA, 2004.
72. J.S. Mason, D.L. Cheney, Pac. Symp. Bio- comput. 2000, 576-587.
73. J.E. Eksterowicz, E. Evensen, C. Lem- men, G.P. Brady, J.K. Lanctot, E.K. Bradley, E. Saiah, L.A. Robinson, P.D. J. Grootenhuis, J.M. Blaney, J. Mol. Graph. Model. 2002, 20, 469-477.
74. R. Barbaro, L. Betti, M. Botta, F. Corelli, G. Giannaccini, L. Maccari, F. Manetti, G. Strappaghetti, S. Corsano, J. Med. Chem. 2001, 44, 2118-2132.
75. G. Zlokarnik, P.D. J.Grootenhuis, J.B.Watson, Drug Discov. Today 2005, 10, 1443-1450.
76. H. Yu, A. Adedoyin, Drug Discov. Today 2003, 8, 852-861.
77. U. Norinder, SAR QSAR Environ. Res. 2005, 16, 1-11.
78. R.P. Sheridan, B.P. Feuston, V.N. Maiorov, S.K. Kearsley, J. Chem. Inf. Comput. Sci. 2004, 44, 1912-1928.
79. M.L. López-Rodríguez, E. Porras, B. Benhamú, J.A. Ramos, M. J. Morcillo, J.L. Lavandera, Bioorg. Med. Chem. Lett. 2000, 10, 1097-1100.
80. A.-C. Egnell, C. Eriksson, N. Albertson, B. Houston, S. Boyer, J. Pharmacol. Exp. Ther. 2003, 307, 878-887.
81. A.-C. Egnell, J.B. Houston, C.S. Boyer, J. Pharmacol. Exp. Ther. 2005, 312, 926- 937.
82. J.A. Kemp, R.M. McKernan, Nat. Neu- rosci. 2002, 5, 1039-1042.
83. M. J. Marino, O. Valenti, P. J. Conn, Drugs Aging 2003, 20, 377-397.
84. G. Marek, Curr. Opin. Pharmacol. 2004, 4, 18-22.
85. C. J. Swanson, M. Bures, M.P. Johnson, A.-M. Linden, J.A. Monn, D.D. Schoepp, Nat. Rev. Drug Discov. 2005, 4, 131-144.
86. R. Dingledine, K. Borges, D. Bowie, S.F. Traynelis, Pharmacol. Rev. 1999, 51, 7-61.
87. J.-P. Pin, F. Acher, Curr. Drug Targets 2002, 297-317.
88. D.F. Ortwine, T.C. Malone, C.F. Bigge, J.T. Drummond, C. Humblet, G. John-son, G.W. Pinter, J. Med. Chem. 1992, 35, 1345-1370.
89. J.P. Whitten, B.L. Harrison, H. J. Weintraub, I.A. McDonald, J. Med. Chem. 1992, 35, 1509-1514.
90. A.-S. Bessis, H.-O. Bertrand, T. Galvez, C.D. Colle, J.-P. Pin, F. Acher, Protein Sci. 2000, 9, 2200-2209.
91. H.-O. Bertrand, A.-S. Bessis, J.-P. Pin, F. Acher, J. Med. Chem. 2002, 45, 3171-3183.
92. F.C. Acher, H.-O. Bertrand, Biopolymers 2005, 80, 357-366.
93. A.-S. Bessis, P. Rondard, F. Gaven, I. Brabet, N. Triballeau, L. Prézeau, F. Acher, J.-P. Pin, Proc. Natl. Acad. Sci. USA 2002, 99, 11097-11102.
94. Accelrys. CAP. Available from Accelrys, Inc., San Diego, CA, in ADE, AEI and Catalyst formats; www.accelrys.com.
95. A.K. Bhattacharjee, J.A. Geyer, C.L. Woodard, A.K. Kathcart, D.A. Nichols, S.T. Prigge, Z. Li, B.T. Mott, N.C. Waters, J. Med. Chem. 2004, 47, 5418- 5426.
96. T.M. Steindl, C.E. Crump, F.G. Hay- den, T. Langer, J. Med. Chem. 2005, 48, 6250-6260.
97. S. Sirois, D.-Q. Wei, Q. Du, K.-C. Chou, J. Chem. Inf. Comput. Sci. 2004, 44, 1111-1122.
98. T. Klabunde, K.V. Wendt, D. Kadereit, V. Brachvogel, H.-J. Burger, A.W. Her- ling, N.G. Oikonomakos, M.N. Kosmo-poulou, D. Schmoll, E. Sarubbi, E. von Roedern, K. Schörafinger, E. Defossa, J. Med. Chem. 2005, 48, 6178-6193.
99. L. Betti, M. Botta, F. Corelli, M. Flori- di, G. Giannaccini, L. Marccari, F. Manetti, G. Strappaghetti, A. Tafi, S. Corsano, J. Med. Chem. 2002, 45, 3603-3611.
100. M.L. López-Rodríguez, F. Porras, M. J. Morcillo, B. Benhamú, L. J. Soto, J.L. Lavandera, J.A. Ramos, M. Olivella, M. Campillo, L. Pardo, J. Med. Chem. 2003, 46, 5628-5650.